Epidemiological Investigation and Risk Factor Analysis of Pulmonary Arterial Hypertension Associated with Portal Hypertension

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025596

Enrollment

Unknown

Registered

2019-09-02

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Arterial Hypertension Associated with Portal Hypertension

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 16-75 years; 2. Clinically diagnosed cirrhosis (by biopsy, imaging examination or clinical manifestation); 3. Obtain informed consent.

Exclusion criteria

Exclusion criteria: 1. Common contraindications for HVPG or right heart catheterizaiton (allergy to contrast, severe infection); 2. Diagnosed malignancies; 3. History or plan of TIPS, liver transplantation, and devascularization of blood vessels after spleen resection; 4. Non-cirrhotic portal hypertension; 5. Portal vein thrombosis or cavernous transformation of portal vein; 6. Pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
mPAP;Description of the general epidemiology of the patient;Ultrasonic Cardiogram;arterial blood gas analysis;hepatic venous pressure gradient;WHO grading;	—

Secondary

Measure	Time frame
NT-pro BNP;	—

Countries

China

Contacts

Public ContactZHANG CHUNQING

Shandong Provincial Hospital

13583188661@163.com+86 15168886028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026